SCHEMBL18472405

SCHEMBL18472405

COc1ccc(NCCO)cc1C[C@@H](CC(=O)OC(C)(C)C)NB(C)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 5/20 0.35
▸ MTNR1B P49286 5/20 0.35
▸ ALDH1A1 P00352 3/20 0.33
▸ NTRK1 P04629 3/20 0.33
▸ GAA P10253 3/20 0.32
▸ ITGA4 P13612 1/20 0.32
▸ ITGB7 P26010 1/20 0.32
▸ CACNA1B Q00975 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ APAF1 O14727 1/20 0.31
▸ TDP2 O95551 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ CASP6 P55212 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18472401 0.88 ALDH1A1 (0.33) ALDH1A1
SCHEMBL28533660 0.86 CACNA1B (0.40) MTNR1AMTNR1BALDH1A1GAAITGA4
SCHEMBL18472406 0.84 MTNR1A (0.34) MTNR1AMTNR1BALDH1A1ITGA4ITGB7
SCHEMBL18472400 0.83 MTNR1A (0.38) MTNR1AMTNR1BALDH1A1GAAITGA4
SCHEMBL18472404 0.80 MEN1 (0.32) MTNR1AMTNR1BLMNAMEN1KMT2A
SCHEMBL18427973 0.78 MMEL1 (0.39) ALDH1A1GAAITGA4ITGB7CACNA1B
SCHEMBL28525859 0.78 MMEL1 (0.39) ALDH1A1GAAITGA4ITGB7CACNA1B
SCHEMBL28515447 0.78 AAK1 (0.41) MTNR1AMTNR1BALDH1A1GAACACNA1B
SCHEMBL28515450 0.78 AAK1 (0.41) MTNR1AMTNR1BALDH1A1GAACACNA1B
SCHEMBL28526967 0.74 AAK1 (0.39) ALDH1A1GAAMAPTMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017459-B2 β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof QUADRIGA BIOSCIENCES, INC. (US) 2018-07-10 — — US disclosed
US-20170362166-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF QUADRIGA BIOSCIENCES, INC. 2017-12-21 — — US disclosed
US-9783487-B2 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof QUADRIGA BIOSCIENCES, INC. (US) 2017-10-10 — — US disclosed
US-20170036992-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF QUADRIGA BIOSCIENCES, INC. 2017-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170036992-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF SLC3A2, SLC7A1, SLC43A1 MTNR1A 3473/4885MTNR1B 3366/4885ALDH1A1 501/4885
US-10017459-B2 β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof SLC7A1, SLC3A2, SLC43A1 MTNR1A 3447/4885MTNR1B 3370/4885ALDH1A1 509/4885
US-20170362166-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF SLC3A2, SLC7A1, SLC43A1 MTNR1A 3473/4885MTNR1B 3366/4885ALDH1A1 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback